Furthermore, elevated levels of anti-PRMT5 antibodies were significantly associated with the presence of interstitial lung disease (ILD) (p < 0.0001) and antinuclear antibody positivity (p < 0.01). This evidence concerns the gene PRMT5 and interstitial lung disease.